Obesity Trial, Recruiting (NCT06129110)

Obesity Trial, Recruiting NCT06129110 Sponsor: University of Colorado, Denver Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT06129110 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Generally healthy men and women between the ages of 18 and 70
People with a Body Mass Index (BMI) between 30 and 40 (a measure of body weight relative to height)
People who do less than 1 hour of exercise per week
Women who are either pre-menopausal (still having periods) or post-menopausal (periods have fully stopped) may be eligible

Who may not be able to join:

People who have Type 1 or Type 2 diabetes
People who have a thyroid condition
People with a history of lung disease
People who are currently using nicotine in any form
People with severe disorders affecting fat levels in the blood
People currently taking hormone replacement therapy, blood thinners, or a type of medication called thiazolidinediones (confirm with trial site)
Women who are currently going through menopause or the transition period leading up to it (peri-menopause)
Women who are pregnant or breastfeeding
Women with a history of Polycystic Ovary Syndrome (a hormonal condition affecting the ovaries)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 3037243919

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06129110

Sponsor: University of Colorado, Denver

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: 3037243919

More information: https://clinicaltrials.gov/study/NCT06129110

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Generally healthy men and women between the ages of 18 and 70
People with a Body Mass Index (BMI) between 30 and 40 (a measure of body weight relative to height)
People who do less than 1 hour of exercise per week
Women who are either pre-menopausal (still having periods) or post-menopausal (periods have fully stopped) may be eligible

Who may not be able to join:

People who have Type 1 or Type 2 diabetes
People who have a thyroid condition
People with a history of lung disease
People who are currently using nicotine in any form
People with severe disorders affecting fat levels in the blood
People currently taking hormone replacement therapy, blood thinners, or a type of medication called thiazolidinediones (confirm with trial site)
Women who are currently going through menopause or the transition period leading up to it (peri-menopause)
Women who are pregnant or breastfeeding
Women with a history of Polycystic Ovary Syndrome (a hormonal condition affecting the ovaries)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Colorado, Denver

Registry

ClinicalTrials.gov

Start date

31 January 2024

Est. completion

1 August 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Insulin Sensitivity; Body Weight; IMAT Content; Muscle Mass; Muscle Strength

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov